The CD4 cell count at the initiation of ART is the most important predictor of disease progression, and determines opportunistic infection (OI) risk stratification, when to start or stop prophylaxis for OI and guidelines for monitoring response to treatment. The gene discussed is CD4; the disease is Opportunistic infection.